The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Toward manipulating sex hormones to modulate the adaptive antitumor immune response in liver cancer.
 
David Bader
No Relationships to Disclose
 
Russell Ericksen
No Relationships to Disclose
 
Suzanne Wardell
Research Funding - Bristol-Myers Squibb (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Radius Health (Inst)
 
Donald McDonnell
Employment - Duke University
Stock and Other Ownership Interests - Adara Therapeutics; G1 Therapeutics; Interdict Bio; Rappta Therapeutics; X-RAD Therapeutics; Zentalis
Consulting or Advisory Role - Bristol-Myers Squibb; G1 therapeutics; Rappta Therapeutics; zentalis
Research Funding - Bristol-Myers Squibb; LQT Therapeutics; Novartis; Precede Bio; Rappta Therapeutics; Ribometrix; Sermonix Pharmaceuticals; Zentalis
Patents, Royalties, Other Intellectual Property - I am an inventor on two patents (assigned to Duke) that covers the use of Lasofoxifene for ESR1 mutant breast cancers. Licensed to Sermonix; Inventor on two patents (Assigned to Duke) licensed to Radius Health covering the use of Rad1901 for Breast cancer.
 
Matthew Hirschey
No Relationships to Disclose